Navigation Links
Synthetic peptide targets latent papilloma virus infections

While a newly marketed vaccine promises to drastically reduce human papilloma virus (HPV) infections, the major cause of cervical cancer, a new discovery by University of California, Berkeley, researchers could some day help the millions of people already infected and at constant risk of genital warts and cancer.

One study found that 75 percent of sexually active men and women under 50 have, or have had, an HPV infection, while 10,000 women annually develop cervical cancer, more than 90 percent of which is caused by HPV. Four thousand women die of cervical cancer each year.

Once infected, it's difficult to rid oneself of the virus because it hides as a latent DNA in cells of the epithelial tissue, such as skin and the lining of the vagina and cervix, and spreads as these cells divide.

The UC Berkeley team created a protein fragment, or peptide, that successfully prevents the virus from hitching a ride on a cell's chromosomes as the cell divides. If such a peptide - or more likely, a drug that mimics the action of the peptide - works in the body, it would effectively stop the virus from spreading or generating warts, which can progress to cancer.

"We're optimistic that this will work generally for many different genetic variants of human papilloma virus, though it's too early to say how many of the genotypes of this virus will respond," said Michael Botchan, professor of molecular and cell biology and a faculty affiliate of the UC Berkeley branch of the California Institute for Quantitative Biology (QB3). "The hope is to have one drug that works for all different human virus types."

"The second most preventable cancer in the world, after lung cancer, is cervical cancer, the result of high HPV infection rates in the developing world, in Asia and South America and Africa," he added. "If we can get something to stop HPV replication, it would have a big health impact."

Botchan, post-doctoral fellow Eric A. Abbate and re
'"/>

Source:University of California - Berkeley


Page: 1 2 3 4

Related biology news :

1. Synthetic Protein Eases Arthritis Symptoms in Mice
2. Synthetic molecule causes cancer cells to self-destruct
3. Product improves peptide identification for proteomics research
4. Discovery clarifies role of peptide in biological clock
5. Frog peptides block HIV in lab study
6. New peptide antibiotic isolated from American oyster
7. Defense peptide found in primates may block some human HIV transmissions
8. Scientists identify 36 genes, 100 neuropeptides in honey bee brains
9. Does a peptide affect the hearts response to social isolation?
10. UCLA AIDS Institute researchers find a peptide that encourages HIV infection
11. A bacterial genome reveals new targets to combat infectious disease

Post Your Comments:
(Date:11/26/2009)... Ecologists have at last worked out a way of using...size of bird populations. This is the first time s...translated into accurate estimates of bird species... in the British Ecological Society,s Journal of A...t could lead to a major advance in our ability to ...
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the ba...ts required to produce a cell that can survive on ...a cell, and understand how an entire organism func...tions that scientists in a partnership between the...eidelberg, Germany, and the Centre de Regulacio Ge...
(Date:11/25/2009)... Ghrelin, a hormone produced in the stomach, may b...pment of Parkinson,s disease, Yale School of Medic...ecent issue of the Journal of Neuroscience . , ... dopamine neurons in an area of the midbrain known... dopamine production. Reduced production of dopam...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Hormone ghrelin can boost resistance to Parkinson's disease 2PharmaTelevision Turns the Media Spotlight Upon BIO Europe 14467 1PharmaTelevision Turns the Media Spotlight Upon BIO Europe 14467 2Sharp HealthCare Selects MEDais Pinpoint Review to Prevent Readmissions 5452 1Sharp HealthCare Selects MEDais Pinpoint Review to Prevent Readmissions 5452 2Sharp HealthCare Selects MEDais Pinpoint Review to Prevent Readmissions 5452 3Sharp HealthCare Selects MEDais Pinpoint Review to Prevent Readmissions 5452 4Record Revenue Growth for Medical Device Software Consulting Firm Full Spectrum Software 14465 1Record Revenue Growth for Medical Device Software Consulting Firm Full Spectrum Software 14465 2
...OneWorld Health, the first nonprofit pharmaceutica...ived Orphan Drug Designation from the two leading ...g Administration (FDA) and the European Agency for...paromomycin to treat visceral leishmaniasis (VL). ...a fatal disease transmitted by sand flies, which s...
...frican legal complaint against British drug maker ...nd policies in that country will proceed following...tion Tribunal that will allow the complaint to go ...case; however, the Competition Tribunal issued an ...thcare Foundation (AHF) and several South African ...
...ve discovered a specialized night-vision brain are...rea might enable the birds to navigate by the star...ld through photoreceptor molecules, whose light-se...hers published their findings May 23, 2005, in the...tional Academy of Sciences. The collaboration was ...
Other Biology News:OneWorld Health drug receives 'Orphan' designation from U.S. and European regulatory agencies 2South African Tribunal Asks For Damages Estimates in GSK AIDS Drug Case 2Migratory songbirds have a specialized night-vision brain area 2
(Date:11/25/2009)... Biotech firm Replikins Ltd., which...e 1918 pandemic through the prediction, outbreak, ...ssued its latest biochemical analysis of the virus...1 ("Swine Flu") virus has dropped from its peak of...k in the spring of 2009 to resting non-epidemic le...
(Date:11/25/2009)...PRNewswire/ - Cytochroma today announced the appoi...rs. Dr. Moldt will replace Mr. Ulrik Spork as the ...e number of Board members remains unchanged at six...ter Moldt to the board and look forward to benefit... continues to make progress in becoming a leading ...
(Date:11/25/2009)...RNewswire-FirstCall/ -- Ardea Biosciences, Inc. (N..., Pharm.D., president and chief executive officer,...lth Care Conference. , ,Presentation details are ... Conference,Date: Tuesday, December 1, 2009,T...w York Palace Hotel, New York, NY,Webcast: <a h...
(Date:11/24/2009)...or to also Visit Detroit , ...ia, French Ambassador for International Investment...ncy, , , , ,What: Ambassador Appia is available t...nitiatives adopted by France to further develop th...ovation and development., , ,When: Available for I...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...hcare Facilities across North ...- Halogen Software Inc., the leading,provider of w...t software,today announced that strong fourth quar... lead as the solution of choice for the healthcare... a number of key accounts,this past quarter includ...
...Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Prod...reports,sharply improved volume of bio-fertilizer ...io-Tech Products (Shandong) Co., Ltd. ("Kiwa,Shand...ting in the,bio-fertilizer industry, sold 114 tons...r of 2007 as compared with 14 tons in the same per...
...more competition from private ...nture capitalists will largely,direct their invest...he,coming year, while China and India remain hot d...nt survey by the U.S. audit, tax and advisory,firm...talists, entrepreneurs, corporate,buyers, investme...
Other Biology Technology:Halogen Advances its Lead in Providing Employee Performance and Talent Management Solutions for the Healthcare Market 2Kiwa Bio-Tech Ships 114 Tons of Bio-Fertilizer in Fourth Quarter of 2007 2Venture Capitalists Bullish on Greentech and Biotech, KPMG Study Says 2Venture Capitalists Bullish on Greentech and Biotech, KPMG Study Says 3
Aedesta Animal Organ/Tissue Perfusion from Lifeblood Medical, Inc.
Rat Anti-Mouse JAM-2 Monoclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-CSNK2A1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
...ementary RNA Spikes for the normalization and cont... printing and for protocol assessment and optimiza...ling, hybridization stringency and background. Nor... Oligo Spots, and complementary RNA Spikes for the...
Biology Products: